Related by context. All words. (Click for frequent words.) 91 allosteric modulator NAM 78 Parkinson disease levodopa induced 76 oral prodrug 75 dyskinesia PD LID 74 Tezampanel 74 mGluR2 positive 74 PEGylated anti 74 Pivotal Phase 73 PEGylated Fab fragment 73 virus HCV protease inhibitor 73 Phase 2b Clinical Trial 73 Solution XOPENEX HFA 73 PNP inhibitor 73 AAG geldanamycin analog 73 Phase IIb Trial 73 oral proteasome inhibitor 73 novel VDA molecule 73 sodium glucose cotransporter 72 TNF Tumor Necrosis Factor 72 Phase 2a Clinical Trial 72 Panzem R 72 pralatrexate injection folate analogue 72 dependent kinase inhibitor 72 Hsp# Inhibitor 72 Randomized Phase 72 topically applied SEPA 72 sodium thiosulfate STS 72 2 methoxyestradiol 72 Meets Primary Endpoint 72 orally administered inhibitor 72 Pivotal Phase III 72 R roscovitine CDK cyclin 72 Ovitrelle R Serostim 72 CYT# potent vascular disrupting 72 pan HDAC inhibitor 72 Solazed TM 72 Elagolix 72 Personalized Immunotherapy 71 pan histone deacetylase 71 mGluR5 NAM 71 non nucleoside inhibitor 71 oral nucleoside analogue 71 JAK1 71 Randomized Double blind 71 Phase IIb Clinical Trial 71 TRANSDUR ® 71 FOLOTYN ® 71 cardiometabolic diseases Glucophage 71 Disease IBD 71 molecular imaging radiopharmaceutical 71 Initiate Phase 71 dasatinib Sprycel ® 71 sapropterin dihydrochloride 71 Trial Evaluating 70 Study Evaluating 70 generation purine nucleoside 70 MKC# MKC# PP 70 N acetylgalactosamine 6 70 methylnaltrexone bromide 70 VEGFR2 inhibitor 70 TO AVOID PREGNANCY WHILE 70 brand ciclesonide HFA 70 Augment TM 70 investigational humanized monoclonal antibody 70 targeted radiotherapeutic 70 somatropin Kuvan R 70 Receives Orphan Drug Designation 70 ocular formulation 70 dihydrochloride Tablets 70 JZP 70 FDA APPROVES 70 candidate AQ4N 70 TRANSDUR ™ 70 Bone Augmentation Material 70 MKC# MT 70 Cannabinor 70 CD# CEA 70 Combination REOLYSIN R 70 phenylalanine ammonia lyase 70 product platforms AZX# 70 Seliciclib CYC# 70 antibody MAb 70 Aflibercept 70 Voreloxin 70 XL# anticancer compounds 70 Inhalation Aerosol 70 Oral Fingolimod 70 Zorbtive TM 70 oral dual endothelin 70 Phase 2b Trial 70 Phase Ib clinical trials 70 Phase IIb trials 70 Locteron ® 70 candidate XP# 70 Cyclooxygenase Inhibiting Nitric Oxide 70 FUSILEV ® 70 lexidronam injection PROSTASCINT 70 ALN HPN 70 Completes Patient Enrollment 70 including eniluracil ADH 70 LymphoStat B belimumab 70 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 70 dextromethorphan quinidine 70 Cleviprex TM clevidipine 69 histone deacetylase HDAC inhibitor 69 PDE4 inhibitor 69 negative allosteric modulator 69 developing Bicifadine serotonin 69 MEK inhibitor 69 Epothilone D 69 highly selective inhibitor 69 First Patient Dosed 69 REG1 Anticoagulation System 69 topical non steroidal 69 liposomal formulation 69 CYP#A# CYP#D# 69 Initiates Phase II 69 2 inhibitor CYT# 69 Safinamide 69 Phase III Clinical Trial 69 Initiates Phase 69 selective immunoproteasome inhibitor 69 Novel Oral 69 transthyretin mediated amyloidosis ATTR 69 Recombinant Human 69 cetuximab Erbitux R 69 rusalatide acetate 69 systemic anaplastic large 69 lintuzumab SGN 69 Completes Enrollment 69 selective androgen receptor modulator 69 class anticancer quinolone 69 humanized interleukin 6 69 investigational pan BCR 69 refractory chronic lymphocytic 69 sodium Injection 69 BENLYSTA TM 69 ABLYNX 69 Wafer polifeprosan 69 MT# MEDI 69 intranasal formulation 69 diarrhea predominant irritable 69 investigational pharmacologically unique 69 R brand arformoterol 69 candidates bavituximab 69 Vascular Disrupting Agent 69 beta 1a 69 lexidronam injection 69 Initiated Phase 69 sorafenib tablets 69 Cetrorelix 69 oncolytic virus therapies 69 CTAP# Capsules 69 abacavir sulfate lamivudine 69 polymerase inhibitor 69 Gel repository corticotropin injection 69 II Clinical Trial 69 treat male hypogonadism 69 evaluating tivozanib 69 alpha folate receptor 69 acyclovir Lauriad R 69 R Saizen R 69 include PLX IBD 69 Omacetaxine 69 을 69 Serdaxin ® 69 cutaneous T 69 SinuNase TM 69 bevacizumab Avastin R 69 Clinical Trial Results 69 dual PPAR peroxisome 69 arsenic trioxide injection 69 Metastatic Melanoma 68 HCV protease inhibitor 68 receptor partial agonist 68 delta opioid receptor 68 SPRYCEL ® 68 Sapacitabine 68 CTA# Injection 68 Presents Positive 68 Initiates Enrollment 68 dihydrochloride 68 receptor tyrosine kinase inhibitor 68 MEK Inhibitor 68 ELADUR ™ 68 Complicated Skin 68 Prodarsan R 68 Genasense ® oblimersen 68 ALN PCS 68 investigational oral inhibitor 68 topical gel formulation 68 MCSP respectively 68 ADX# 68 samarium Sm 68 Veronate R 68 huC# DM4 68 sunitinib Sutent ® 68 investigational antiplatelet agent 68 TKB# 68 catheter occlusion 68 PROCTOCORT R Cream Hydrocortisone 68 Angiotensin Converting Enzyme 68 Oral Suspension Oral Suspension 68 telomerase therapeutic 68 mertansine 68 CDK inhibitor 68 acute peripheral arterial 68 Patient Enrollment 68 drug pipeline TAFA# 68 PHX# 68 cell lymphoma CTCL 68 Acetate Rectal Suppositories 68 Traficet EN 68 Carfilzomib 68 PROSTASCINT R 68 occlusion PAO 68 delivers fluocinolone acetonide FA 68 TLK# 68 Tanespimycin 68 hypertrichosis occurred 68 tiapamil 68 5 FU leucovorin 68 inhaled formulation 68 Orally administered 68 PRICE GREAT DISCOUNT FREE 68 POSIDUR TM ELADUR TM 68 peripherally acting 68 IMPDH inhibitor 68 interferon beta 1a infertility 68 Xanafide 68 5 HT6 68 WRX STi +# mins 68 PDX pralatrexate 68 Luveris R Ovidrel R 68 induced macular edema 68 generation proteasome inhibitor 68 triciribine phosphate monohydrate 68 selective antagonist 68 TRO# 68 combines bupropion 68 Telaprevir VX 68 phase IIb clinical 68 candidates Azedra 68 Initiates Clinical Trials 68 registrational trial 68 R bisoprolol Euthyrox 68 Dose Ranging Study 68 Controlled Trial 68 Drug Candidate 68 CB2 selective receptor agonist 68 hypoxia activated prodrug 68 Investigational Compound 68 IMiDs R 68 Ozarelix 68 Agonist MABA program 68 phenyl salicylate methylene blue 68 Copegus ® 68 mitogen activated ERK kinase 68 vapreotide acetate 68 erlotinib Tarceva ® 68 Peginterferon alfa 2a 68 Diovan Exforge Tekturna Zelnorm 68 Randomized Double Blind 68 individualized cellular immunotherapy 68 ABL inhibitor 68 familial amyloidotic polyneuropathy FAP 68 allosteric modulator PAM 68 bucindolol hydrochloride 68 TELINTRA R 68 2A receptor agonist 67 Luramist TM 67 candidate ridaforolimus 67 metabolic disorders Saizen R 67 R metformin Concor 67 6 sulfatase 67 Xeloda ® 67 Presents Preclinical Data 67 Telik logo TELINTRA 67 Xcytrin R 67 Glufosfamide 67 orally bioavailable 67 Randomized Double Blind Placebo 67 DNA methyltransferase inhibitors 67 PEGINTRON TM 67 Preclinical Data 67 Mg Usa 67 intravesical infusion therapy 67 agonistic human 67 Phase 2a Trial 67 Lubiprostone 67 Janus kinase 67 HuMax EGFr 67 ergot derivatives 67 forodesine 67 IL# PE#QQR 67 injectable polymer 67 docetaxel Taxotere R 67 candidates Azedra TM 67 candidates Augment ™ 67 Microplasmin 67 Solazed ™ 67 ADP receptor antagonist 67 HDAC Inhibitor 67 potent CYP#A# inhibitors 67 ALVESCO ® 67 TELINTRA 67 NOTE POSIDUR ™ 67 small molecule thrombopoietin 67 Brentuximab Vedotin SGN 67 myelofibrosis polycythemia vera 67 CAREFULLY READ THESE MATERIALS 67 systemic RNAi therapeutic 67 albiglutide 67 Intravenous Human 67 AVONEX ® 67 multicenter Phase III 67 Kinase Inhibitor 67 RON Notch 67 PRN FDA Approves 67 VALSTAR R 67 trastuzumab Herceptin R 67 Ceflatonin R 67 include Phenoptin TM 67 anticancer compound 67 product candidate Lpathomab 67 metaglidasen 67 Zemiva ™ 67 Oral NKTR 67 refractory cutaneous T 67 FEMALES SHOULD BE ADVISED 67 Tesetaxel 67 Dapagliflozin 67 PARI Pharma GmbH 67 treat opioid induced 67 REPRONEX ® menotropins 67 vinca alkaloid 67 R#/MEM # 67 ERBITUX cetuximab 67 proliferator activated receptor 67 By JENNIFER LEARN 67 sapropterin dihydrochloride Phase 67 Palifosfamide 67 Pivotal Study 67 BY JIM HANNAH 67 Commences Phase 67 BY ERIN MURPHY 67 Well Tolerated 67 6R BH4 67 Phase III Pivotal 67 OTCQX QRXPY 67 pseudobulbar affect PBA 67 KNS # 67 CCX# B 67 INCB# [003] 67 diarrhea fatigue asthenia 67 IAP inhibitor 67 HCV protease 67 Pooled Analysis 67 sapropterin dihydrochloride Tablets 67 targeting Inflammatory Bowel 67 Humanized Anti 67 VIVITROL ® 67 AFFECT MICROSEMI 'S 67 Phase 2a Study 67 Antitumor Activity 67 formerly LymphoStat B 67 hyperphenylalaninemia HPA due 67 acetonide FA 67 CD4 monoclonal antibody 67 hepatology portfolio 67 modified glutathione analog 67 BY MARC SILVESTRINI 67 By JAMAAL ABDUL 67 Alfacell proprietary ribonuclease 67 Pivotal Trial 67 Double Blind Placebo 67 % hydrocortisone acetate 67 HuCAL PLATINUM ® CysDisplay 67 protein tyrosine phosphatase 1B 67 administered subcutaneously 67 generation antisense inhibitor 67 Previously Treated 67 hyaluronidase enzyme 67 Phase #b/#a clinical 67 polyneuropathy HIV DSP 67 BY SUE KIESEWETTER 67 compound perifosine 67 Injectable Bone Graft 67 Pharmacokinetics PK 67 Nabi HB ® 67 CHEAP ONLINE PHARMACY LOW 67 FOLFOX6 chemotherapy regimen 67 D aspartate NMDA receptor 67 CHARACTER INTERNALLY WITH EXPOSED 67 novel orally inhaled 67 AWAY FROM WINDOWS 67 Loceryl ® 67 therapeutically inactive prodrug 67 한다 67 pentadentate logo R 67 Serostim ® 67 telomerase inhibitor drug 67 Presents Preclinical 67 Epratuzumab 67 Aurora Kinase 67 AEG# 67 benzoic acid hyoscyamine sulfate 67 selective kinase inhibitor 67 armodafinil Tablets C 67 candidate deforolimus 67 ELADUR TM 67 HCl PEPCID ® famotidine 67 Empatic TM 67 R brand levalbuterol 67 iobenguane 67 PEG PAL PEGylated recombinant 67 phenylketonuria PKU developed 67 Topline Results 67 registrational Phase 67 muscarinic receptor agonist 67 MET VEGFR2 67 oxybutynin ATD TM 67 highly purified pasteurized 67 metformin HCl 67 Oral Solution VISICOL 67 oral isoform selective HDAC 67 sarcoma melanoma 67 reversible inhibitor 67 long acting muscarinic 66 Inhalation Solution 66 inflammatory PDE 66 evaluating picoplatin 66 ODT metoclopramide HCl PEPCID 66 CDK cyclin dependent 66 novel histone deacetylase 66 oral isotype selective HDAC 66 TO PREDICT 66 proprietary polysaccharide 66 IMiDs ® compound 66 DDP# 66 ACTEMRA TM 66 BY CHARLIE MORASCH ARKANSAS 66 compound INCB# 66 Factor Receptor 66 Single Dose 66 BCG refractory carcinoma 66 trial evaluating PRX# 66 HAS CHARM AND 66 docetaxel Taxotere ® 66 XP# XP# 66 Initiates Clinical Trial 66 generation Hsp# inhibitor 66 一位 66 alvespimycin 66 Liposomal 66 Hormone Refractory Prostate Cancer 66 Eluting Stent 66 Staphylococcus aureus Immune Globulin 66 Frozen Shoulder syndrome Adhesive 66 Methylnaltrexone 66 BEAMS STONE AND WOODWORK 66 Files IND 66 prokinetic agent 66 Friedreich Ataxia FRDA 66 Jari Ketomaa Subaru Impreza 66 Archexin 66 AVE# 66 Phase IIa Clinical Trial 66 Ocrelizumab 66 metabotropic glutamate receptor 66 ALVESCO R 66 leading oral taxane 66 Amigal TM 66 THESE CONDITIONS NOT 66 Trodusquemine MSI 66 relapsed refractory multiple myeloma 66 NS5B polymerase 66 injection USP 66 Phase 2a clinical trials 66 hormone LHRH antagonist 66 의 을 66 reversible inhibitors 66 IS FOR INFORMATIONAL 66 selective phosphodiesterase 66 MKC# 66 TBC# 66 Cortoss TM 66 POLYSHIELD ® POLYCLEAR ® 66 Monotherapy 66 documented candidiasis 66 Ambrisentan 66 vesicular monoamine transporter 66 에 을 66 MATERIALLY FROM CURRENT EXPECTATIONS 66 Locteron combines 66 imatinib Gleevec ® 66 influenza BCX# purine nucleoside 66 alfa 2a 66 XL# XL# XL# 66 Alocrest 66 BY RYAN ERNST 66 GATTEX TM 66 QNEXA ® 66 IMiD 66 SIDE EFFECTS CHEAP ONLINE 66 non splenectomized 66 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 66 SAR# [002] 66 GVAX ® 66 Naproxcinod 66 non constipating irritable 66 Vicriviroc 66 fosbretabulin 66 LARGE CAP FUND SHOULD 66 modulator SERM 66 PRT# 66 BYETTA ® 66 lenalidomide Revlimid R 66 tartrate Inhalation Aerosol BROVANA 66 Preclinical studies suggest 66 IMiDs ® 66 Ondansetron Injection USP 66 NGX# 66 toenail onychomycosis 66 BY NELL SMITH ARKANSAS 66 Investigational Oral 66 Evo +# mins 66 signal transduction inhibitor 66 Evo IX +# mins 66 nanofiltered plasma derived 66 BiovaxID TM 66 RNAi Therapeutic 66 developing Zerenex TM 66 CHEAP ONLINE PHARMACY BEST 66 multi kinase inhibitor 66 AAMORINI@COMMUNITYPRESS.COM 66 RANK Ligand inhibitor 66 5 HT3 antagonist 66 By THERESA CAMPBELL 66 sapacitabine CYC# 66 mu opioid receptor antagonist 66 CD3 monoclonal antibody 66 c Raf kinase 66 aripiprazole Abilify 66 Receives Orphan Drug 66 도 66 FORWARD LOOKING STATEMENTS INVOLVE 66 oral dihydropyrimidine dehydrogenase DPD 66 polysaccharide polymer 66 BY STEVE KEMME 66 personalized cellular immunotherapy 66 plus Copegus R 66 ® famotidine 66 IN PATIENTS WITH 66 Mylan Receives Approval 66 Refractory Peripheral T 66 Successfully Completes Phase 66 HGS ETR2 66 Pegasys ® 66 metabolic inhibitor 66 Bortezomib 66 interferon gamma 1b 66 arsenic trioxide injection GABITRIL 66 PEGylated interferon beta 1a 66 small molecule defensin 66 PKC# 66 chronic eosinophilic leukemia 66 humanized anti 66 것이다 66 PROCTOCORT ® Suppository Hydrocortisone 66 corticotropin injection 66 selective modulator 66 R famotidine 66 AN# topical anti 66 Lenocta TM 66 DECISION WITH RESPECT TO 66 HGS ETR1 mapatumumab 66 R lenalidomide 66 transthyretin TTR mediated amyloidosis 66 Histone Deacetylase 66 Medoxomil 66 unique alkylating agent 66 tumor xenograft models 66 Pressemitteilung ist der jeweilige 66 visilizumab 66 BY DUSTIN DOW 66 BNA THE METEOROLOGY 66 clinical trials Archexin ® 66 release capsules FENTORA 66 lamotrigine Lamictal 66 JAK2 Inhibitor 66 platinum chemotherapeutic 66 AND ACTUAL RESULTS 66 PRTX 66 overactive bladder AA# 66 tretinoin #.# 66 refractory gout 66 PDGFR B 66 COVER YOUR BODY 66 MicroMacro TM Multi 66 SRUSSELL@ENQUIRER.COM 66 essential thrombocythemia ET 66 JAK inhibitor 66 BRIM2 66 HGS ETR1 66 delivered RNAi therapeutic 66 intravenous ghrelin agonist 66 oral rivaroxaban 66 TH STAFF WRITER 66 purpura ITP 66 DIURIL R 66 cyclobenzaprine hydrochloride extended 66 GATTEX ® 66 Phase III Trial 66 salmeterol inhalation powder 66 REPRONEX R menotropins 66 Treatment Naïve 66 OR REVISE ANY FORWARD 66 Iluvien ® 66 Vidaza R 66 THE CONSENT SOLICITATION 66 PEGASYS ® 66 Granted Orphan Drug 66 Mg Uk 66 ara C 66 WINTER WEATHER CONDITIONS ARE 66 vitreoretinal disorders 66 tezampanel 66 Crofelemer budesonide foam 66 irreversible inhibitor 66 OF WILLIAM JENACK 66 Orthop Surg 66 GVAX R 66 DURECT proprietary 66 AN INDICATION OF 66 THAT COULD CAUSE ACTUAL 66 rNAPc2 66 seliciclib CYC# 66 对 的 66 investigational monoclonal antibody 66 CORTOSS R 66 pathophysiological effects 66 Entereg R 66 BY JONATHAN SHUGARTS 66 LymphoStat B TM 66 ® brand levalbuterol 66 novel topoisomerase 65 VentiRx Pharmaceuticals 65 REVIVE Diabetes 65 octreotide implant 65 MATERIALLY FROM THOSE 65 Sangamo BioSciences Announces 65 non alcoholic steatohepatitis 65 includes investigational compounds 65 Pruvel ™ 65 antibody MT# 65 或者 65 diaper dermatitis complicated 65 YOU WOULD CHANGE 65 PROCTOCORT R 65 RhuDex ® 65 orally inhaled migraine 65 human C1 inhibitor 65 INVESTORS AND SHAREHOLDERS ARE 65 dimebon latrepirdine 65 allosteric modulator 65 Preclinical Efficacy 65 Maribavir 65 Advanced Renal Cell 65 Iloperidone 65 IV FENTORA R 65 placebo controlled Phase 65 ALN TTR 65 Suppository Hydrocortisone Acetate Rectal 65 Inc. Nasdaq CYCC 65 Intermezzo ® zolpidem tartrate 65 ARRY # 65 HCV NS5B polymerase 65 WRX +# mins 65 selective adhesion molecule 65 SWOT ANALYSIS 65 Initiate Clinical Trial 65 Monoclonal Antibody 65 luteinizing hormone releasing 65 LENALIDOMIDE 65 Potassium Chloride Sodium Ascorbate 65 XL# XL# 65 receiving INTRON 65 Oral Solution OSMOPREP 65 NDA Submission 65 includes TOLAMBA TM 65 Novacort TM 65 * olmesartan medoxomil 65 Phase Ib study 65 Testosterone MDTS R 65 ® sodium phosphate 65 Exherin 65 ferumoxytol Injection 65 PATENT FOR 65 Vaccine Recombinant 65 BY REBECCA GOODMAN 65 entinostat 65 Phase 2b Study 65 OR REFLECT THE 65 monoclonal antibody conjugated 65 MEK inhibitor RDEA# 65 ABOUT YOUR JOB 65 Relapsed Refractory 65 HCV polymerase inhibitors 65 brand eszopiclone XOPENEX 65 small molecule Hedgehog 65 Soriatane R 65 OTCBB PYTO 65 INCB# [001] 65 Clolar ® 65 Onalta ™ 65 RISKS UNCERTAINTIES AND OTHER 65 GLP1 INT TM 65 compound PMX # 65 Oracea TM 65 이다 65 BY ROBERT LOWELL 65 retinal vein occlusion induced 65 PD LID 65 acetylgalactosamine 6 65 BY JAMES MCNAIR 65 Romidepsin 65 label Lipofen R 65 colesevelam HCl 65 BUPHENYL 65 Initiates Phase III 65 大学 英语 65 Cardium Therapeutics TM 65 R rilonacept Injection 65 S1P antibody 65 TO ITS ACCURACY 65 Leukine ® 65 TNF alpha selectively neutralizing 65 Preclinical Study 65 ALVESCO 65 Placebo Controlled 65 AND RELATED LETTER OF 65 Denufosol 65 BLIZZARD WARNING MEANS SEVERE 65 BNA PRIME MINISTER SHAIKH 65 Pafuramidine 65 AND COMPRISES CANOPY PORCH 65 Release Tablets 65 treat benign prostatic 65 Belimumab 65 kidney urologic 65 Affinity Optimized Antibody 65 Linaclotide 65 Pharmacokinetic Study 65 AMCG DEST FISH HUDV 65 Refractory Hodgkin Lymphoma 65 metastatic malignant 65 IS BEING MADE ONLY 65 Initiates Clinical 65 BUSINESS DAYS OF 65 RNAi therapeutic targeting 65 INVOLVE RISKS AND UNCERTAINTIES 65 BY JENNIFER EDWARDS 65 EnteroMedics proprietary neuroblocking technology 65 NEBIDO R 65 Rebif ® 65 Testosterone MDTS ® 65 THIS SITE AT 65 proteasome inhibitor 65 Company NASDAQ OMRI 65 uricase 65 candidate MyVax 65 vaccines oncolytic virus 65 R memantine HCl 65 Randomized Phase II 65 % pramoxine HCl 65 E. SHEELEY • 65 Amrubicin 65 Albuferon TM 65 TRX1 65 candidate iSONEP TM 65 Exherin TM 65 BENLYSTA ™ 65 xanthine oxidase inhibitor 65 所 的 65 CONTAIN FORWARD LOOKING STATEMENTS 65 Ostabolin C TM 65 Pegloticase 65 NU# direct 65 iloprost synthetic compound 65 orally inhaled 65 Perifosine KRX 65 가 65 WHICH MAY CAUSE 65 adenosine injection 65 NEWS RELEASE CONSTITUTE FORWARD 65 Oral Insulin 65 orBec R oral beclomethasone 65 PROVENGE ® 65 vascular disrupting agent 65 JAK Inhibitor 65 PLEASE READ THESE TERMS 65 Investigational eFlow Nebulizer System 65 Navelbine ® 65 RISKS AND UNCERTAINTIES THAT 65 PGAL SHOW 65 Ranolazine 65 ARE ONLY PREDICTIONS 65 Saizen ® 65 mocetinostat MGCD# 65 AND CONDITIONS OF 65 reslizumab 65 worsening thrombocytopenia 65 Æterna Zentaris Inc. 65 systemic juvenile idiopathic 65 ZEVALIN ® 65 class mGluR5 inhibitor 65 TRIOLEX ™ 65 Achieves Primary Endpoint 65 과 65 BY TRACIE DUNGAN ARKANSAS 65 cortisol synthesis 65 Phase III Trials 65 DG# compounds targeting 65 INSPIRE Trial Phase III 65 수 65 GlycoPEGylated hemostasis compounds 65 LEVADEX TM 65 Central Retinal Vein 65 Elvitegravir 65 PSN# [002] 65 Restoraderm R 65 rALLy clinical trial 65 ENTRANCE HALL CLOAKROOM WC 65 Cutaneous T 65 DEBT AND IDENTITY 65 development peramivir neuraminidase 65 EDEMA3 65 Adagen ® 65 Ofatumumab 65 PROCTOCORT R Suppository Hydrocortisone 65 THEREON 65 herpetic keratitis 65 AREAS AFFECTED 65 Inhalation Powder 65 II TRISENOX R 65 mg QD 65 Coadministration 65 WHAT IS ONE THING 65 myelodysplastic myeloproliferative diseases 65 四 六级 65 Zoraxel TM 65 indinavir Crixivan 65 DU #b 65 篇 65 Cloretazine ® 65 ATRA IV 65 polymerase inhibitors 65 Tolvaptan 65 topoisomerase II inhibitor 65 ® tiagabine hydrochloride 65 positive allosteric modulator 65 IS NOT INDICATIVE OF 65 FOLFOX6 65 Ophena TM 65 BY LAURA KELLAMS ARKANSAS 65 Chronic Hepatitis C 65 Tocilizumab 65 BY ROB WEILER 65 nucleoside analog 65 primary hypercholesterolemia 65 inhibitor PPI 65 Pimavanserin 65 Vitrasert R 65 aldehyde dehydrogenase ALDH2 deficiency 65 selective inverse agonist 65 BUSINESS ECONOMIC COMPETITIVE 65 PRODUCT DEFINITIONS 65 cell carcinoma RCC 65 PHARMACEUTICALS INC 65 potent inhibitor 65 ITS ENTIRETY BECAUSE 65 AND FITNESS FOR 65 mg Suppository Hydrocortisone Acetate 65 Inc. AMEX YMI 65 Spectrum Pharmaceuticals Announces 65 Advancing Drugs 65 ® chorionic gonadotropin 65 MCURNUTTE@ENQUIRER.COM 65 markets HP Acthar 65 SPL# Gel vaginal microbicide 65 PRIOR TO MAKING ANY 65 oral picoplatin 65 Cream USP 1 65 CORT # 65 biomodulator 65 Talabostat 65 EGFR HER2 65 somatostatin analog 65 Golimumab 65 novel orally administered 65 Demonstrates Significant 65 CCR9 antagonist 65 VERIFICATION OF THE 65 ITS REGULATION PROVIDER AS 65 Luteinizing Hormone Releasing Hormone 65 Saxagliptin 65 Sudhir Agrawal D.Phil 65 motexafin gadolinium Injection 65 PURPOSES ONLY AND 65 INFeD R 65 octreotide acetate 65 chemosensitizer 65 * LW# * 65 Inc. NASDAQ AEZS 65 Systemic Sclerosis 65 BY JANE PRENDERGAST 65 Irinotecan 65 advanced metastatic renal 65 CysDisplay R 65 IS INTENDED FOR DISTRIBUTION 65 GMX# 64 Copegus R 64 YONDELIS R 64 AND CONSENT SOLICITATION 64 Commence Phase 64 但是 64 dasatinib Sprycel 64 TAFA# 64 Investigational Treatment 64 Phase IIIb 64 vinorelbine tartrate 64 WINS STAGE 64 Phase IIa trials 64 products MKC# PP 64 Azedra TM 64 #.#secs P 64 peptidic compound 64 Vidaza ® 64 THOSE ANTICIPATED IN 64 ACOOLIDGE@ENQUIRER.COM 64 Peginterferon alfa 2b 64 Vaprisol 64 Therapeutic Competitors Companies 64 inhalation aerosol 64 하는 64 Nasdaq XTLB 64 erlotinib Tarceva R 64 dipropionate 64 PEG SN# 64 Aganocide 64 MIVI III 64 无法 64 nilotinib Tasigna ® 64 investigational compounds 64 SPOKE TO HER MOTHER 64 irinotecan doxorubicin oxaliplatin paclitaxel 64 的 中 64 Chlorothiazide AZASAN R 64 TRIAL OF 64 Prodarsan ® 64 FACTORS THAT CAN MATERIALLY 64 CONTAINS FORWARD LOOKING STATEMENTS 64 R bendamustine hydrochloride 64 为 的 64 cisplatin gemcitabine 64 Eltrombopag 64 VEGF receptors 64 ADL# novel 64 investigational immunotherapy 64 CORDURA ® CORFREE ® 64 norepinephrine reuptake inhibitor 64 Myelofibrosis 64 Placebo Controlled Trial 64 Parathyroid Hormone 64 Pruvel TM 64 DIURIL ® Chlorothiazide AZASAN 64 Phase 2b clinical trials 64 RGOODMAN@ENQUIRER.COM 64 했다 64 PhosLo R 64 R tiagabine hydrochloride NUVIGIL 64 는 의 64 dexamethasone Decadron 64 ARIKACE 64 BY JOHN ECKBERG 64 Inc. Nasdaq OXGN 64 PUBLISHED RATINGS CRITERIA AND 64 oral ridaforolimus 64 Immunotherapeutic 64 MAY CAUSE THE 64 candesartan cilexetil 64 hypoxia selective 64 TRANSFORMS 64 Fludara ® 64 immunotherapeutic agent 64 Azacitidine 64 multicenter placebo controlled 64 Clinical Trial Evaluating